BeiGene (NASDAQ:BGNE) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Analysts have set 12-month price targets for BeiGene, revealing an average target of $232.12, a high estimate of $288.00, and a low estimate of $152.50. This current average has increased by 8.3% from the previous average price target of $214.33. Understanding Analyst Ratings: A Compreh…